Human leukocyte interferon-α treatment for chronic HCV-related hepatitis in hemophilic patients previously intolerant to other interferons-α

Digestive Diseases and Sciences

Volumn 47, Issue 2, 2002, Pages 427-431

  Dughera, Luca ^a   Battaglia, Edda ^a   Serra, Anna Maria ^a   Tibaudi, Daniela ^a   Buonafede, Giuseppina ^a   Navino, Monica ^a   Schinco, Piercarla ^a   Tamponi, Giacomo ^a   Emanuelli, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Chronic hepatitis C; Hemophilia; Intolerance; Leukocyte interferon

Indexed keywords

ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; POSTTRANSFUSION HEPATITIS; PRIORITY JOURNAL; SIDE EFFECT; VON WILLEBRAND DISEASE;

FOLLOW-UP STUDIES; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; TIME FACTORS; VON WILLEBRAND DISEASE;

EID: 0036161744     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013798812144     Document Type: Article

References (26)

1. The natural history of chronic Hepatitis C in haemophiliacs
2. Chronic hepatitis C virus infection in haemophilic patients: Clinical significance of viral phenotype
3. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contamined with hepatitis C
4. A prospective multicenter study of hepatocellular carcinoma in Italian haemophiliacs with chronic hepatitis C
5. Interferon-α therapy for chronic hepatitis C in special patient population
6. A comparison of RT-PCR and bDNA assays for hepatitis C virus in patients receiving interferon treatment
7. The role of liver biopsy in haemophiliacs infected with the hepatitis C virus
8. Investigations of chronic hepatitis C infection in individuals with haemophilia
9. Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment
10. Platelet and white blood cell counts during therapy with different types of alpha interferon in patients with chronic viral hepatitis
11. Interferon alpha-induced depression in chronic hepatitis C patients: Comparison between different types of interferon alpha
12. Incidence of electrocardiographic abnormalities during treatment with human leukocyte interferon alpha in patients with chronic hepatitis C but without pre-existing cardiovascular disease
13. Low dose leukocyte interferon-α therapy in dialysed patients with chronic hepatitis C
14. Formation of antibodies to factor VIII in patients with haemophilia A who are treated with interferon for chronic hepatitis C
15. Effectiveness of leukocyte interferon-α treatment in patients with chronic hepatitis C not responsive to recombinant Interferon
16. Human leukocyte interferon-α in chronic hepatitis C resistent to recombinant or lymphoblastoid interferon-α: A randomised controlled trial
17. Resistence to recombinant alpha interferon therapy in idiopathic mixed cryoglobulinemia: Reinduction of remission by natural alpha interferon both in antibody positive and negative patients
18. Leukocyte interferon α retreatment for chronic hepatitis C patients previously intolerant to other interferons
19. Human leukocyte interferon alpha: Structure, pharmacology and therapeutic applications
20. Development of anti-interferon antibodies and break through hepatitis during treatment for HCV infection in haemophiliacs
21. 2b treatment of anti-human immunodeficiency virus negative haemophilic patients with chronic hepatitis C
22. 2a-interferon in chronic hepatitis C
23. High dose long-term therapy of α interferon in haemophiliac patients with chronic C virus hepatitis
24. High prevalence of serum cryoglobulins in multitransfused haemophilic patients with chronic hepatitis C
25. Interferon alpha- 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
26. Alpha 2b interferon alone or in combination with ribavirin for retreatment of interferon relapse of chronic hepatitis C. International hepatitis interventional therapy group